Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,631,000 | 9,474,000 | 11,240,000 | 16,927,000 | 17,940,000 |
| Marketable Securities | 12,721,000 | 13,382,000 | 15,943,000 | 10,977,000 | 12,149,000 |
| Receivables | 3,582,000 | 3,315,000 | 3,396,000 | 3,283,000 | 3,327,000 |
| Inventories | 922,000 | 882,000 | 884,000 | 898,000 | 814,000 |
| TOTAL | $30,296,000 | $28,361,000 | $33,727,000 | $34,024,000 | $35,836,000 |
| Non-Current Assets | |||||
| PPE Net | 4,502,000 | 4,377,000 | 4,249,000 | 4,116,000 | 4,006,000 |
| Investments And Advances | 1,488,000 | 2,195,000 | 3,051,000 | 2,221,000 | 1,423,000 |
| Intangibles | 17,903,000 | 18,981,000 | 19,269,000 | 19,555,000 | 19,855,000 |
| Other Non-Current Assets | 7,438,000 | 5,232,000 | 2,914,000 | 2,921,000 | 2,555,000 |
| TOTAL | $31,331,000 | $30,785,000 | $29,483,000 | $28,813,000 | $27,839,000 |
| Total Assets | $61,627,000 | $59,146,000 | $63,210,000 | $62,837,000 | $63,675,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,499,000 | 2,498,000 | 1,999,000 | 2,498,000 | 2,748,000 |
| Accounts payable and accrued liabilities | 713,000 | 632,000 | 617,000 | 577,000 | 790,000 |
| Accrued Expenses | 3,473,000 | 3,652,000 | 3,585,000 | 3,974,000 | 3,928,000 |
| TOTAL | $9,759,000 | $9,567,000 | $8,961,000 | $9,397,000 | $10,605,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,103,000 | 22,991,000 | 25,661,000 | 24,080,000 | 25,614,000 |
| Other Non-Current Liabilities | 6,122,000 | 5,855,000 | 5,842,000 | 7,276,000 | 5,922,000 |
| TOTAL | $29,218,000 | $28,843,000 | $31,498,000 | $31,349,000 | $31,536,000 |
| Total Liabilities | $38,977,000 | $38,410,000 | $40,459,000 | $40,746,000 | $42,141,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,263,637 | 1,265,146 | 1,266,455 | 1,271,555 | 1,275,511 |
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | 19,388,000 | 17,616,000 | 19,829,000 | 19,326,000 | 19,024,000 |
| Other shareholders' equity | 210,000 | 249,000 | 237,000 | 270,000 | 227,000 |
| TOTAL | $22,650,000 | $20,736,000 | $22,751,000 | $22,091,000 | $21,534,000 |
| Total Liabilities And Equity | $61,627,000 | $59,146,000 | $63,210,000 | $62,837,000 | $63,675,000 |